Rocha Alcides, Arbex Flavio F, Alencar Maria Clara N, Sperandio Priscila A, Hirai Daniel M, Berton Danilo C, O'Donnell Denis E, Neder J Alberto
Pulmonary Function and Clinical Exercise Physiology Unit (SEFICE), Division of Respirology, Federal University of Sao Paulo, Sao Paulo, Brazil.
Pulmonary Function and Clinical Exercise Physiology Unit (SEFICE), Division of Respirology, Federal University of Sao Paulo, Sao Paulo, Brazil; Laboratory of Clinical Exercise Physiology and Respiratory Investigation Unit, Queen's University, Kingston General Hospital, Kingston, ON, Canada.
Int J Cardiol. 2016 Dec 1;224:447-453. doi: 10.1016/j.ijcard.2016.09.077. Epub 2016 Sep 24.
Exercise oscillatory ventilation (EOV) is associated with poor ventilatory efficiency and higher operating lung volumes in heart failure. These abnormalities may be particularly deleterious to dyspnea and exercise tolerance in mechanically-limited patients, e.g. those with coexistent COPD.
Ventilatory, gas exchange and sensory responses to incremental exercise were contrasted in 68 heart failure-COPD patients (12 EOV+). EOV was established by standard criteria.
Compared to EOV-, EOV+ had lower exercise capacity, worse ventilatory inefficiency and higher peak dyspnea scores (p<0.05). Peak capillary PCO (PcCO) was higher and end-tidal CO (PETCO) was lower in EOV+. Thus, greater (i.e., more positive) P(c-ET)CO and dead space/tidal volume values were found in these patients compared to EOV- (p<0.05). Ventilatory inefficiency was related to increased dead space/tidal volume in EOV+ (r=0.74; p<0.01). Owing to higher operating lung volumes, inspiratory reserve volume (IRV) decreased to a greater extent in EOV+. Tidal volume oscillations consistently ceased when a "critical" IRV was reached (~0.3-0.5L); thereafter, PcCO stabilized or increased and dyspnea scores rose sharply. Exercise capacity was closely related to IRV decrements and peak dyspnea in EOV+ (r=-0.78 and 0.84, respectively; p<0.01).
Dyspnea and exercise tolerance are negatively influenced by EOV in heart failure patients presenting with COPD as co-morbidity. Pharmacological and non-pharmacological interventions known to decrease EOV might prove particularly valuable to mitigate symptom burden and exercise intolerance in this specific heart failure group.
运动振荡通气(EOV)与心力衰竭患者通气效率低下及较高的工作肺容积有关。这些异常情况对于机械通气受限的患者,例如合并慢性阻塞性肺疾病(COPD)的患者,可能对呼吸困难和运动耐力特别有害。
对比了68例心力衰竭合并COPD患者(其中12例存在EOV)在递增运动时的通气、气体交换及感觉反应。EOV通过标准标准确定。
与无EOV的患者相比,存在EOV的患者运动能力较低、通气效率较差且峰值呼吸困难评分更高(p<0.05)。存在EOV的患者毛细血管二氧化碳分压峰值(PcCO)更高,而呼气末二氧化碳分压(PETCO)更低。因此,与无EOV的患者相比,这些患者的(动脉-呼气末)二氧化碳分压差更大(即更正),死腔/潮气量值更高(p<0.05)。在存在EOV的患者中,通气效率低下与死腔/潮气量增加有关(r=0.74;p<0.01)。由于工作肺容积较高,存在EOV的患者吸气储备容积(IRV)下降幅度更大。当达到“临界”IRV(约0.3-0.5L)时,潮气量振荡持续停止;此后,PcCO稳定或升高,呼吸困难评分急剧上升。在存在EOV的患者中,运动能力与IRV下降及峰值呼吸困难密切相关(分别为r=-0.78和0.84;p<0.01)。
合并COPD的心力衰竭患者中,EOV对呼吸困难和运动耐力有负面影响。已知可降低EOV的药物和非药物干预措施可能对减轻该特定心力衰竭群体的症状负担和运动不耐受特别有价值。